Afatinib With CT and RT for EGFR-Mutant NSCLC
Clinical trial NCT01553942 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01553942
- Sponsor
- Massachusetts General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2024-12-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.